News & Events
R&D Magazine - February 14 2014
In this opinion piece, Michael Groner, VP engineering and chief architect, and Trevor Heritage, VP of corporate development and strategy, explain that the barriers to precision medicine aren’t technological, but logistical—connecting currently siloed capabilities to make genomic testing easier for physicians everywhere to implement..
Big data firm to help NIH’s Undiagnosed Disease Program commercialize its genetic analysis techniques
MedCity News - January 30 2014
Appistry CEO Kevin Haar and William Gahl, director the NIH Undiagnosed Diseases Program, explain to Deanna Pogorelc discuss how scaling the NIH UDP diploid aligner pipeline will assist in identifying candidate genes that may be associated with rare diseases.
Appistry to Commercialize Informatics Pipeline, Provide Analysis Services for NIH's Rare Diseases Program
GenomeWeb - January 24 2014
Uduak Thomas interviews Appistry CEO Kevin Haar and William Gahl and Cornelius Boerkoel of the NIH Undiagnosed Diseases Program about their partnership to commercialize the NIH UDP’s diploid aligner pipeline.